Transoral robotic thyroidectomy vs. Open thyroidectomy for thyroid cancer: A propensity Score-Matched analysis
Journal of Robotic Surgery · 19.03.2026 · 20 (1)
DOI: 10.1007/s11701-025-03050-5 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Robotic Surgery, online erschienen am 19.03.2026. Verfasst von Fu Luo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Thyroid Surgery, Daping Hospital, Army Medical University, Changjiang Route #10, Daping, Chongqing, 400042, China. Hauptthemen laut MEDLINE: Thyroidectomy, Robotic Surgical Procedures, Thyroid Neoplasms. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Chongqing Natural Science Foundation, University Scientific and Technological Innovation Capacity Enhancement Programme, Centre 'Artificial Intelligence+' Medical Research Programme.
Abstract (Originalsprache)
Transoral robotic thyroidectomy (TORT) offers a virtually scarless outcome but requires comparative validation studies against open thyroidectomy (OT). Patients who underwent thyroid surgery at our institution between January 2020 and October 2024 were enrolled. Through propensity score matching analysis, a final cohort of 322 adults with pathologically confirmed thyroid carcinoma was identified, comprising 161 patients in each group. We analyzed and compared clinical outcomes between the two surgical cohorts, along with patient-reported outcomes including Numerical Rating Scale (NRS) for pain, Voice Handicap Index-10 (VHI-10), and Scar Assessment Questionnaire-Cosmetic (SAQCO) for scar satisfaction assessed at 1 week postoperatively. Among the 322 propensity score-matched patients (age: median [IQR]: 41.0 [34.0, 51.0] years vs. 43.0 [34.0, 52.0] years; 231 females [71.7%], 91 males [28.3%]), the TORT group demonstrated significantly higher operative costs (median [IQR]: ¥63,351.0 [60,644.5, 64,948.8] vs. ¥19,009.6 [17,127.7, 21,774.4]; P < .001, BH-corrected q = 0.002) and longer operative duration (mean [SD]: 242.0 [55.8] min vs. 106.3 [38.4] min; mean difference: 136 min, 95% Cl: 125 - 146; P < .001, BH-corrected q = 0.002) compared to the OT group. However, the TORT group had significantly shorter postoperative hospitalization (mean [SD]: 2.8 [1.4] days vs. 3.4 [1.2] days; mean difference: -0.6 days; 95% Cl: 0.31- 0.88; P < .001, BH-corrected q = 0.002) and a lower incidence of transient hypoparathyroidism (5/161 [3.1%] vs. 29/161 [18.0%]; risk difference: -14.9, 95% Cl:-20.3 to -9.5; RR: 0.19, 95% Cl: 0.08 - 0.45); P < .001, BH-corrected q = 0.002). Patient-reported outcomes favored TORT, with significantly lower: NRS pain scores (median [IQR]: 3.0 [2.0, 4.0] vs. 7.0 [6.0, 8.0]; median difference: -4.0, 95% CI: -5.0 to -4.0; P < .001, BH-corrected q = 0.002). VHI-10 scores (median [IQR]: 38.0 [12.0, 59.0] vs. 77.0 [59.0, 89.0]; median difference: -39.0; 95% CI: -42.0 to -29.0; P < .001, BH-corrected q = 0.002). Conversely, scar satisfaction assessed via the SAQCO was significantly higher in the TORT group (median [IQR]: 20.0 [18.0, 23.0] vs. 14.0 [12.0, 17.0]; median difference: 6.0; 95% CI: 5.0 to 6.0; P < .001). No significant intergroup differences existed in lymph nodes harvested (median [IQR]: 7.0 [4.0, 11.0] vs. 8.0 [5.0, 12.0]; P = .06, BH-corrected q = 0.10) or metastatic lymph nodes dissected (median [IQR]: 0 [0, 2] vs. 1 [0, 3]; P = .06, BH-corrected q = 0.10). TORT achieves non-inferior perioperative outcomes compared to OT, with superior cosmetic results, reduced hospitalization duration. However, incurs significantly higher costs and longer operative times.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Breast and Thyroid Surgery, Daping Hospital, Army Medical University, Changjiang Route #10, Daping, Chongqing, 400042, China.
- Department of Breast and Thyroid Surgery, Daping Hospital, Army Medical University, Changjiang Route #10, Daping, Chongqing, 400042, China. xy931@163.com.
- Key Laboratory of Chongqing Health Commission for Minimally Invasive and Precise Diagnosis and Treatment of Breast Cancer, Chongqing, China. xy931@163.com.
Förderung
- Chongqing Natural Science Foundation
- University Scientific and Technological Innovation Capacity Enhancement Programme
- Centre 'Artificial Intelligence+' Medical Research Programme
- Centre ‘Artificial Intelligence+’ Medical Research Programme
Zitieren
APA
Luo, F., Xu, J., Zhang, G., Jiang, Y., Guo, L., Yu, F., Yan, J., & Xu, Y. (2026). Transoral robotic thyroidectomy vs. Open thyroidectomy for thyroid cancer: A propensity Score-Matched analysis. Journal of Robotic Surgery, 20(1). https://doi.org/10.1007/s11701-025-03050-5
Vancouver
Luo F, Xu J, Zhang G, Jiang Y, Guo L, Yu F, et al. Transoral robotic thyroidectomy vs. Open thyroidectomy for thyroid cancer: A propensity Score-Matched analysis. Journal of Robotic Surgery. 2026;20(1). doi:10.1007/s11701-025-03050-5
BibTeX
@article{Luo2026,
author = {Luo, Fu and Xu, Jing and Zhang, Gang and Jiang, Yan and Guo, Lingji and Yu, Fan and Yan, Jie and Xu, Yan},
title = {Transoral robotic thyroidectomy vs. Open thyroidectomy for thyroid cancer: A propensity Score-Matched analysis},
journal = {Journal of Robotic Surgery},
year = {2026},
volume = {20},
number = {1},
doi = {10.1007/s11701-025-03050-5}
}
EUVIMED